Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Carcinoma to the Uterine Cervix”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02921269
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+4 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)WithdrawnNCT07146919
What this trial is testing

AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer

Who this might be right for
Endometrial CarcinomaOvarian CancerCervix Cancer
Centre Leon Berard
Testing effectiveness (Phase 2)UnknownNCT05557565
What this trial is testing

A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Qilu Pharmaceutical Co., Ltd. 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07542717
What this trial is testing

ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 41
Testing effectiveness (Phase 2)Study completedNCT04868708
What this trial is testing

AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Akeso 50
Large-scale testing (Phase 3)Looking for participantsNCT07418749
What this trial is testing

SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent Cervical CancerMetastatic Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 398
Testing effectiveness (Phase 2)Study completedNCT03438396
What this trial is testing

A Trial of Tisotumab Vedotin in Cervical Cancer

Who this might be right for
Cervical Cancer
Seagen Inc. 102
Testing effectiveness (Phase 2)UnknownNCT05247619
What this trial is testing

A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Zhejiang Cancer Hospital 49
Not applicableNot Yet RecruitingNCT06062589
What this trial is testing

AK104 Combined With I-125 Brachytherapy for Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Peking University Third Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT04865887
What this trial is testing

Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

Who this might be right for
Cervical CancerMetastatic Cervical Cancer
Georgetown University 35
Post-approval studies (Phase 4)Looking for participantsNCT06952660
What this trial is testing

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Pfizer 100
Early research (Phase 1)Ended earlyNCT00004261
What this trial is testing

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Who this might be right for
Breast CancerCervical CancerHead and Neck Cancer+2 more
University Health Network, Toronto
Large-scale testing (Phase 3)UnknownNCT05446883
What this trial is testing

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Who this might be right for
METASTATIC CERVICAL CANCER
Qilu Pharmaceutical Co., Ltd. 498
Testing effectiveness (Phase 2)Study completedNCT01026792
What this trial is testing

Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+5 more
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Looking for participantsNCT07256236
What this trial is testing

SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Fujian Cancer Hospital 89
Large-scale testing (Phase 3)Looking for participantsNCT06692166
What this trial is testing

Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Mabwell (Shanghai) Bioscience Co., Ltd. 420
Testing effectiveness (Phase 2)UnknownNCT05179317
What this trial is testing

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Qilu Pharmaceutical Co., Ltd. 60
Large-scale testing (Phase 3)Ended earlyNCT04864782
What this trial is testing

QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Qilu Pharmaceutical Co., Ltd. 46
Large-scale testing (Phase 3)Active Not RecruitingNCT06459180
What this trial is testing

Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

Who this might be right for
Cervical Cancer
Merck Sharp & Dohme LLC 686
Testing effectiveness (Phase 2)UnknownNCT04623333
What this trial is testing

TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 80
Next Page